Private Equity Firm to Purchase Johnson & Johnson Ortho-Clinical Business for $4.15B

Carlyle Group, a private equity firm, has agreed to purchase Johnson & Johnson's ortho-clinical testing business for $4.15 billion, according to a Mass Device report. The diagnostics business works with screening, monitoring and identifying diseases. Carlyle plans to expand the business into emerging and established markets.

More Articles on Devices:
Aurora Spine Earns Nearly $10M in Private Placement of Common Shares
Tegra Medical Names J. Mark King as CEO
Stan Janosz Joins Phillips Precision Medicraft as Director of Continuous Improvement